eXV2 CMS Multiple Cross Site Scripting Vulnerabilities
BID:44169
Info
eXV2 CMS Multiple Cross Site Scripting Vulnerabilities
| Bugtraq ID: | 44169 |
| Class: | Input Validation Error |
| CVE: |
CVE-2010-4155 |
| Remote: | Yes |
| Local: | No |
| Published: | Oct 15 2010 12:00AM |
| Updated: | Apr 13 2015 09:02PM |
| Credit: | Liquidworm |
| Vulnerable: | |
| Not Vulnerable: | |
Discussion
eXV2 CMS Multiple Cross Site Scripting Vulnerabilities
eXV2 CMS is prone to multiple cross-site scripting vulnerabilities because it fails to properly sanitize user-supplied input.
An attacker may leverage these issues to execute arbitrary script code in the browser of an unsuspecting user in the context of the affected site. This can allow the attacker to steal cookie-based authentication credentials and launch other attacks.
eXV2 CMS 2.10 is vulnerable; other versions may also be affected.
eXV2 CMS is prone to multiple cross-site scripting vulnerabilities because it fails to properly sanitize user-supplied input.
An attacker may leverage these issues to execute arbitrary script code in the browser of an unsuspecting user in the context of the affected site. This can allow the attacker to steal cookie-based authentication credentials and launch other attacks.
eXV2 CMS 2.10 is vulnerable; other versions may also be affected.
Exploit / POC
eXV2 CMS Multiple Cross Site Scripting Vulnerabilities
Attackers can exploit these issues by enticing an unsuspecting victim into following a malicious URI.
The following example URIs are available:
Attackers can exploit these issues by enticing an unsuspecting victim into following a malicious URI.
The following example URIs are available:
Solution / Fix
eXV2 CMS Multiple Cross Site Scripting Vulnerabilities
Solution:
Currently we are not aware of any vendor-supplied patches. If you feel we are in error or if you are aware of more recent information, please mail us at: [email protected].
Solution:
Currently we are not aware of any vendor-supplied patches. If you feel we are in error or if you are aware of more recent information, please mail us at: [email protected].